NCT00805064View on ClinicalTrials.gov

Combined Triple Procedure in Retinal Vein Occlusion (RVO)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

November 30, 2008

Conditions
Retinal Vein Occlusion
Interventions
DRUG

triamcinolone and bevacizumab

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00805064 - Combined Triple Procedure in Retinal Vein Occlusion (RVO) | Biotech Hunter | Biotech Hunter